Recombinant Interleukin-11 Prolonged Therapy Linked to Cardiac Effects in Severe Thrombocytopenia
In a new retrospective cohort analysis published in BMC Pharmacology and Toxicology, researchers report on the cardiac consequences of extended recombinant human interleukin-11 (rhIL-11) therapy...















